This insider cluster is routine and non-informative. The sales are small in dollar terms, tied to option exercises, and likely driven by tax obligations or diversification. No bearish read-through is warranted. Monitor for any material change in insider behavior (e.g., a C-suite member selling >5% of their stake without a corresponding option exercise).
Price Chart
Executive Summary
Three top insiders at United Therapeutics — the CEO, CFO, and General Counsel — executed a cluster of open-market sales totaling ~$1.76M over a 7-day window. All sales were part of a coordinated pattern of option exercises and same-day share dispositions, consistent with routine tax-related selling rather than a bearish signal. The total value represents ~0.008% of the company's $23.1B market cap, well below the materiality threshold.
Key Financial Metrics
Key Facts
- CEO Martine Rothblatt sold 1,462 shares at ~$544.89 on June 8, netting ~$797K
- CFO James Edgemond sold 1,565 shares at ~$544.93 on June 8, netting ~$853K
- EVP Paul Mahon sold 200 shares at ~$539.76 on June 4, netting ~$108K
- All sales were preceded by same-day option exercises at $0 or $117.76–$146.03 strike prices
- Total open-market sales of ~$1.76M represent ~0.008% of UTHR's $23.1B market cap
- No open-market purchases were made by any insider during the window
Financial Impact
Total insider sales of ~$1.76M, or ~0.008% of market cap — trivial relative to company size
Risk Factors
- No material risk identified from this insider activity
- If future filings show a shift to larger, unplanned open-market sales by multiple C-suite members, that would warrant a reassessment
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-UTHR-1781042793178 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $500.35 $497.31 | ▼ −0.61% | ▼ −2.72% | $573.51 (+14.62%) |
Sep 11, 2026 21d ago | Insider Cluster | $497.11 $494.63 | ▼ −0.50% | ▼ −0.28% | $573.51 (+15.37%) |
Sep 10, 2026 22d ago | Insider Cluster | $503.86 $497.27 | ▼ −1.31% | ▼ −0.81% | $573.51 (+13.82%) |
Sep 9, 2026 23d ago | Insider Cluster | $506.82 $498.48 | ▼ −1.65% | ▼ −0.99% | $573.51 (+13.16%) |
Sep 4, 2026 28d ago | Insider Cluster | $487.61 $502.70 | ▲ +3.09% | ▲ +4.30% | $573.51 (+17.62%) |
Sep 3, 2026 29d ago | Insider Cluster | $488.16 $497.11 | ▲ +1.83% | ▲ +2.98% | $573.51 (+17.48%) |
Aug 28, 2026 5w ago | Insider Cluster | $515.46 $487.61 | ▼ −5.40% | ▼ −5.51% | $573.51 (+11.26%) |
Aug 27, 2026 5w ago | Insider Cluster | $527.91 $492.02 | ▼ −6.80% | ▼ −6.03% | $573.51 (+8.64%) |
Aug 26, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $573.51 (+11.00%) |
Aug 25, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $573.51 (+11.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access